Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210030912 210021520 1.54 82 Curative (C) 2017-07-29 2017-10-08 FLAIR Trial N N 210031313 FLAIR TRIAL
210030913 210021523 null null null 2018-06-19 2018-06-30 BENDAMUSTINE + RITUXIMAB N N 210031354 BENDAMUSTINE + RITUXIMAB
210030914 210011798 null 94 Disease modification (D) null 2015-02-09 FLAIR Trial N N 210031381 FLAIR TRIAL
210030915 210011814 1.83 76 Adjuvant (A) 2017-08-30 2017-08-30 VINCRISTINE N N 210031465 VINCRISTINE
210030917 210011824 1.8 103.6 Disease modification (D) 2016-03-22 2017-12-26 BENDAMUSTINE + RITUXIMAB N N 210031507 BENDAMUSTINE + RITUXIMAB
210030918 210027520 1.72 83 Disease modification (D) 2015-02-06 2015-10-07 Vincristine (weekly) N N 210031512 VINCRISTINE
210030919 210011832 1.59 null Palliative (P) null 2018-01-30 FLAIR Trial 02 N 210031516 FLAIR TRIAL
210030920 210011839 1.79 62.9 null 2014-02-01 2014-03-17 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N 210031542 FCR
210030921 210011840 1.6 86.8 Disease modification (D) 2016-11-25 2016-11-28 FCR Oral - Cycle 2 onwards 02 N 210031543 FCR
210030922 210011845 null 78 Palliative (P) 2016-07-31 2016-09-27 Vincristine (weekly) 02 N 210031570 VINCRISTINE
210030923 210011857 1.79 109.8 Adjuvant (A) 2017-10-15 2017-10-21 FCR N N 210031647 FCR
210030924 210011861 1.63 89.6 Disease modification (D) 2017-08-09 2017-08-09 VINCRISTINE 01 null 210031677 VINCRISTINE
210030925 210011864 1.57 72.4 Disease modification (D) 2013-08-22 2014-01-01 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB null N 210031682 FCR
210030927 210011873 1.8 null null 2015-12-22 2015-12-22 BENDAMUSTINE + RITUXIMAB null N 210031749 BENDAMUSTINE + RITUXIMAB
210030928 210011885 null null null 2014-07-07 2014-07-07 Bendamustine+Rituximab(Sub Courses) N N 210031805 BENDAMUSTINE + RITUXIMAB
210030929 210011889 1.8 null Curative (C) 2014-09-16 2014-12-04 FLAIR Trial Y N 210031811 FLAIR TRIAL
210030930 210011895 1.73 82.6 Palliative (P) 2013-10-25 2013-12-30 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N 210031827 FCR
210030931 210011899 1.57 68.7 Curative (C) 2015-01-22 2015-11-02 FCR Oral - Cycle 2 onwards Y N 210031850 FCR
210030932 210011899 1.6 65.2 Curative (C) 2017-10-14 2017-11-21 BENDAMUSTINE + RITUXIMAB 02 N 210031850 BENDAMUSTINE + RITUXIMAB
210030933 210011904 1.59 64 Palliative (P) null 2016-06-13 FCR Oral - Cycle 2 onwards N N 210031879 FCR
210030934 210011912 1.65 null null 2013-02-25 2013-05-17 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB null null 210031944 FCR
210030935 210011915 1.55 69.6 Curative (C) 2017-02-25 2017-09-10 FCR Oral - Cycle 2 onwards N N 210031959 FCR
210030936 210011919 null 44 Palliative (P) 2016-06-30 2016-09-14 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB Y N 210032019 FCR
210030937 210011925 null 96 Disease modification (D) null 2013-12-18 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N 210032021 FCR
210030938 210021596 1.57 54 Palliative (P) 2013-11-24 2014-07-18 FCR Oral - Cycle 2 onwards N N 210032022 FCR
210030939 210011936 1.71 91.4 Palliative (P) 2015-11-24 2016-01-28 BENDAMUSTINE + RITUXIMAB N N 210032066 BENDAMUSTINE + RITUXIMAB
210030940 210011955 1.78 66.6 Disease modification (D) 2016-02-06 2016-02-06 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB null N 210032274 FCR
210030941 210011959 1.8 137.6 Palliative (P) 2014-06-15 2014-08-12 FCR Oral - Cycle 2 onwards N N 210032287 FCR
210030942 210011961 1.7 100.2 Palliative (P) 2016-02-13 2016-04-14 FLAIR Trial N N 210032293 FLAIR TRIAL
210030943 210011962 1.72 72.7 Palliative (P) 2014-08-16 2014-09-20 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB 2 N 210032310 FCR
210030944 210011972 null 78 Disease modification (D) 2017-03-12 2017-03-19 BENDAMUSTINE + RITUXIMAB N null 210032412 BENDAMUSTINE + RITUXIMAB
210030945 210021621 1.76 144 Curative (C) 2017-07-08 2017-07-08 Bendamustine+Rituximab(Sub Courses) N N 210032422 BENDAMUSTINE + RITUXIMAB
210030946 210011985 null 103.6 Curative (C) 2013-08-15 2013-09-16 Vincristine (weekly) N N 210032491 VINCRISTINE
210030947 210011986 null null Curative (C) 2017-06-06 2017-06-21 FCR N N 210032497 FCR
210030948 210011988 1.64 null Curative (C) 2014-12-22 2014-12-22 BENDAMUSTINE + RITUXIMAB 02 N 210032500 BENDAMUSTINE + RITUXIMAB
210030949 210021628 1.73 104 Curative (C) 2013-07-01 2014-04-30 FCR Oral - Cycle 1 N N 210032509 FCR
210030950 210011994 1.84 null Curative (C) 2016-08-20 2016-11-02 Vincristine (weekly) N null 210032534 VINCRISTINE
210030951 210035051 1.75 108 Disease modification (D) null 2016-09-06 Bendamustine+Rituximab(Sub Courses) N N 210032535 BENDAMUSTINE + RITUXIMAB
210030952 210011998 1.84 90 Curative (C) 2014-09-11 2014-09-12 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N 210032549 FCR
210030954 210012000 1.8 112.8 Palliative (P) 2018-03-30 2018-07-14 FLAIR Trial null N 210032559 FLAIR TRIAL
210030955 210027585 1.47 78.6 Disease modification (D) 2017-10-24 2017-11-27 BENDAMUSTINE + RITUXIMAB null N 210032573 BENDAMUSTINE + RITUXIMAB
210030956 210036132 1.78 77.9 Curative (C) 2015-02-13 2015-05-06 FLAIR Trial N N 210032574 FLAIR TRIAL
210030957 210012005 1.84 24.7 Palliative (P) 2017-10-29 2017-12-07 Vincristine (weekly) 02 N 210032587 VINCRISTINE
210030958 210012008 1.72 134.2 Curative (C) 2016-12-13 2017-02-23 Bendamustine+Rituximab(Sub Courses) N N 210032608 BENDAMUSTINE + RITUXIMAB
210030959 210031225 1.54 42 Palliative (P) 2013-02-12 2013-05-12 FCR Oral - Cycle 2 onwards null null 210032625 FCR
210030960 210021641 null 10.5 Disease modification (D) null 2016-07-05 BENDAMUSTINE + RITUXIMAB N N 210032638 BENDAMUSTINE + RITUXIMAB
210030961 210012019 null null Neo-adjuvant (N) 2012-10-29 2014-10-27 FLAIR Trial 01 N 210032683 FLAIR TRIAL
210030962 210012031 1.54 33.5 Adjuvant (A) 2013-07-10 2013-09-19 FCR Oral - Cycle 2 onwards 02 N 210032731 FCR
210030963 210021653 1.59 102 Disease modification (D) 2018-10-28 2018-12-08 Vincristine (weekly) 01 N 210032734 VINCRISTINE
210030964 210012036 null 93.5 Curative (C) 2019-01-28 2019-02-05 FCR Oral - Cycle 2 onwards null N 210032743 FCR